Correction Published: 2025 Article title: REG/Reg family proteins: mediating gut microbiota homeostasis and implications in digestive diseases Authors: Qi, Z., Pang, W., Zha, X., Liu, Y., Liu, S., Xiao, F., …… Liu, X Journal: Gut Microbes DOI: https://doi.org/10.1080/19490976.2025.2568055 The correct version of Table 4, Table 5 and “The role of REG/Reg family in liver cancer” is provided below have been included in the original article, and it has been republished accordingly. Table 4.The role of REG/Reg family in intestinal tumor diseases.MemberCorrelation with microecologyConclusionRef.REG1AREG4REG1A expression (mRNA/protein) is upregulated in CRC tissues, with elevated serum levels in patients vs. healthy controls. REG4 is overexpressed in CRC tissues; its serum levels increase in stage IV patients and significantly correlate with liver metastasis.Abnormal REG1A/REG4 expression correlates significantly with CRC inflammatory microenvironment, tumor invasion, and lymph node metastasis; REG4 serves as a biomarker for predicting CRC invasiveness and prognosis; Combination with other indicators enhances CRC screening and diagnostic efficacy.[20]REG3AIn CRC tissues, the mRNA levels were significantly upregulated, demonstrating high expression.High REG3A expression promotes CRC cell proliferation/migration and inhibits apoptosis via AKT/ERK1/2 activation. Its expression significantly correlates with larger tumor size, poor differentiation, reduced survival, and tumor progression.[140]REG1AREG3AREG1A mRNA is higher in CRC than normal tissues, and serum REG1A/REG3A is elevated in patients.High REG1A/REG3A correlates with CRC's inflammatory microenvironment, lymph node/liver metastasis.[137]Reg4mRNA and protein expression levels of Reg4 in CRC tissues are significantly upregulated; Highly expressed in SW480 and HT29 cell lines, but weakly expressed in HCT116 cells.Reg4 activates the Akt-GSK3β-β-Catenin-TCF4 signaling pathway; Inhibits GSK3β phosphorylation to promote β-Catenin nuclear translocation and induce the expression of Cyclin D1, c-Myc, etc.[107]Reg4REG4 is highly expressed in CRC tissues. Its mRNA is elevated in HT-29 but not LoVo cells; however, Reg4 protein is significantly expressed in Reg4-transfected LoVo cells. Serum Reg4 correlates significantly with liver metastasis and is elevated in stage IV CRC patients.REG4 enhances CRC cell migration/invasion via its CRD domain and serves as a potential serum biomarker for predicting invasion/metastasis. Its expression correlates with malignant progression and poor prognosis, while CRD deletion abolishes Reg4's prometastatic function.[138]Reg3βIn Bmi1/Mel18 DKO mouse IECs, Reg3β expression was significantly upregulated but absent in Reg3βΔIEC mice. In human CRC tissues, REG3β negatively correlated with pSTAT3 levels.Reg3β inhibits CRC progression by suppressing IL-6/IL-11-mediated STAT3 signaling, reducing tumor proliferation and promoting apoptosis. Its expression serves as a prognostic marker, with high levels predicting favorable outcomes.[22]REG4REG4 mRNA/protein were significantly upregulated in human CRC vs. adjacent tissues. It was highly expressed in HT29/LS180/DLD-1 cells but not HCT116. miR-363 overexpression suppressed REG4 via GATA6 inhibition.REG4 is a direct GATA6 target that promotes CRC anchorage-dependent proliferation/tumorigenesis via GATA6-REG4 signaling. miR-363 suppresses CRC growth by inhibiting GATA6-REG4/LGR5, indicating therapeutic potential.[108] The role of REG/Reg family in intestinal tumor diseases. Table 5.The role of REG/Reg family in intestinal infection diseases.MemberCorrelation with microecologyConclusionRef.Reg3βReg3β-deficient mice show elevated Salmonella levels in colon, mesenteric lymph nodes, spleen, and liver versus WT mice, but fecal shedding remains unchanged.Reg3β alleviates salmonellosis by specifically binding to surface components of Gram-negative bacteria and interfering with their invasion mechanisms, but has no effect on listeriosis.[69]Reg3βReg3β exerts dose-dependent bactericidal effects on commensal bacteria (E. coli, Clostridium butyricum), but shows no killing activity against Salmonella.Salmonella induces Reg3β expression to eliminate competing microbiota, thereby promoting its own overproliferation and colonization in the intestine.[70]Reg3β/γC. rodentium shows low susceptibility to Reg3β/γ; fecal pathogen counts in Reg3β-deficient Mouse are significantly higher than in wild-type.Reg3β/γ are IL-22-driven antimicrobial effectors, but their deficiency alone doesn’t compromise host defense against C. rodentium; IL-22’s protective role depends on multi-pathway synergy, with Reg3β/γ serving as auxiliary components.[75]Reg3α/β/γIn Western diet-fed mouse, A. muciniphila is nearly eliminated, while facultative anaerobes (Proteobacteria) overproliferate.Western diet disrupts the jejunal mucosal antimicrobial barrier, accompanying reduced expression of jejunal Reg3α/β/γ genes and levels of Reg3α/β proteins in mucus.[95]Reg3βFollowing oral Y. pseudotuberculosis infection, TLR2−/− mice exhibit higher bacterial burdens in Peyer's patches and markedly reduced survival compared to WT.TLR2 induces Reg3β expression by sensing microbial signals, enhancing intestinal epithelial pathogen clearance; this mechanism depends on commensal bacteria signals and the MyD88 pathway.[141] The role of REG/Reg family in intestinal infection diseases. The role of REG/Reg family in liver cancer The REG/Reg family exerts dual roles in hepatocellular carcinoma (HCC) across precancerous, oncogenic/progressive stages, and liver injury repair, modulating cell proliferation, apoptosis, inflammation, glycosylation, and gut-liver axis signals, while some members support targeted therapy or liver injury alleviation to reduce HCC risk (Figure 7). During the precancerous stage, high Reg3A expression in the livers of cirrhotic patients directly binds to glycosyl substrates of the HBP pathway via lectin activity, reducing UDP-GlcNAc levels and inhibiting O-GlcNAc glycosylation of Myc at threonine 58 [143]. This modification (O-GlcNAc glycosylation of Myc) typically enhances Myc stability, whereas Reg3A intervention renders Myc more susceptible to ubiquitin-proteasome pathway-mediated degradation, thereby inhibiting Myc-driven cell proliferation signals and significantly prolonging cancer-free survival [143].